Anthony L. Boral, Chief Medical Officer at Blueprint Medicines Corp (BPMC), sold 19,785 shares at $118.72 ($2.3M) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $2.3M BPMC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.75 | 215 | $25K | 1.1% |
| 2 | $117.92 | 1,970 | $232K | 9.9% |
| 3 | $117.92 | 1,970 | $232K | 9.9% |
| 4 | $118.72 | 7,815 | $928K | 39.6% |
| 5 | $118.72 | 7,815 | $928K | 39.6% |
| Total | $118.54 avg | 19,785 |
| $2.3M |
| 100% |
| Filing → |
| BPMC | SELL | 2020-03-11 | $28K | — | Filing → |
| BPMC | SELL | 2019-12-19 | $1.5M | — | Filing → |
| BPMC | SELL | 2019-08-22 | $801K | — | Filing → |